Solid Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	61.36	80.24	74.02	155.38	119.14	154.74
Short-Term Investments	174.78	68.69	49.63	58.34	88.64	-
Cash & Short-Term Investments	236.14	148.92	123.64	213.72	207.78	154.74
Cash Growth	38.00%	20.45%	-42.15%	2.86%	34.27%	85.27%
Receivables	-	-	-	-	0.11	-
Prepaid Expenses	3.11	1.65	2.11	3	8.71	1.48
Other Current Assets	5.6	6.73	3.98	2.91	6.02	2.67
Total Current Assets	244.85	157.3	129.73	219.64	222.61	158.9
Property, Plant & Equipment	26.89	29.04	33.16	38.61	7.6	11.73
Other Long-Term Assets	2.17	2.32	2.04	2.01	2.16	0.54
Total Assets	273.91	188.66	164.94	260.25	232.38	171.17
Accounts Payable	8.43	4.24	2.03	3.24	4.46	3.27
Accrued Expenses	19.05	19.85	10.16	16.69	9.53	8.64
Current Portion of Leases	2.31	3.02	2.32	2.57	1.5	2.21
Current Unearned Revenue	-	-	-	-	8.08	10.36
Other Current Liabilities	6.55	3.15	-	0.01	0.04	-
Total Current Liabilities	36.34	30.26	14.52	22.51	23.6	24.48
Long-Term Leases	19.62	21.16	23.94	25.98	0.57	2.94
Long-Term Unearned Revenue	-	-	-	-	-	10.36
Other Long-Term Liabilities	-	-	-	0.1	-	1.3
Total Liabilities	55.97	51.42	38.46	48.59	24.17	39.08
Common Stock	0.08	0.04	0.02	0.02	0.01	0.09
Additional Paid-In Capital	1,126	920.61	785.2	774.45	685.01	536.57
Retained Earnings	-907.99	-783.45	-658.75	-562.74	-476.76	-404.57
Comprehensive Income & Other	0.05	0.05	0.02	-0.07	-0.05	-
Total Common Equity	217.95	137.25	126.48	211.67	208.21	132.09
Shareholders' Equity	217.95	137.25	126.48	211.67	208.21	132.09
Total Liabilities & Equity	273.91	188.66	164.94	260.25	232.38	171.17
Total Debt	21.94	24.18	26.27	28.55	2.06	5.15
Net Cash (Debt)	214.21	124.74	97.38	185.18	205.72	149.59
Net Cash Growth	46.32%	28.11%	-47.41%	-9.98%	37.52%	95.66%
Net Cash Per Share	2.88	3.06	4.90	21.75	28.90	43.20
Filing Date Shares Outstanding	77.91	77.49	37.76	19.57	7.36	5.68
Total Common Shares Outstanding	77.88	40.47	20.39	19.56	7.36	5.66
Working Capital	208.51	127.05	115.22	197.13	199.01	134.42
Book Value Per Share	2.80	3.39	6.20	10.82	28.30	23.34
Tangible Book Value	217.95	137.25	126.48	211.67	208.21	132.09
Tangible Book Value Per Share	2.80	3.39	6.20	10.82	28.30	23.34
Machinery	-	16.1	17.92	17.96	11.37	10.27
Construction In Progress	-	0.88	0.41	1.72	1.49	1.33
Leasehold Improvements	-	0.47	0.48	0.38	4.71	4.71

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q